The Wall Street Transcript is a completely unique resource for investors and business researchers.

Please tell us about Puma Biotechnology. Mr. Auerbach: I’d be more than happy to. Puma is a biotech company that is dedicated to the development and commercialization of drugs for the treatment of ...

Uzi Sofer is CEO and Chairman of Alpha Tau Medical Ltd. Mr. Sofer specializes in medical device development, regulation, reimbursement and marketing, and has more than 20 years of experience in ...

Vlad Vitoc, M.D., is Chairman of Board, Chief Executive Officer, and President of MAIA Biotechnology Inc. Dr. Vitoc has a broad array of experience across commercial strategic analysis and ...

Erez Aminov is the Chairman and Chief Executive Officer of MIRA Pharmaceuticals, Inc., a biopharmaceutical company developing treatments for neuropsychiatric disorders. In addition, Mr. Aminov ...

Cuong Do is President and CEO of BioVie Inc. Prior to his appointment with BioVie, Mr. Do was President of Samsung Global Strategy Group where he helped to set the strategic direction for Samsung ...

Hartaj Singh is a Founding Partner of Tecumseh Partners, advising biotech companies on valuation, strategy, and investor engagement. He also writes The Biotech Capital Compass, a newsletter ...

Jason Wittes is a Managing Director and Senior Research Analyst at Roth Capital Partners. He has over 20 years of health care investment experience on both the buy side and sell side. Prior to ...

Steven M. Lichtman is Managing Director and Senior Analyst for medical devices at Oppenheimer & Co. Inc. Mr. Lichtman has been on the sell side following the medical devices sector for over 20 ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

The Wall Street Transcript is a completely unique resource for investors and business researchers.